These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12072703)

  • 21. Continuous arteriovenous hemofiltration for acute renal failure.
    Bartlett RH; Bosch J; Geronemus R; Paganini E; Ronco C; Swartz R
    ASAIO Trans; 1988; 34(1):67-77. PubMed ID: 3288257
    [No Abstract]   [Full Text] [Related]  

  • 22. A dialysis alternative more nurses can run.
    Dirkes SM
    RN; 1997 May; 60(5):20-5; quiz 26. PubMed ID: 9205402
    [No Abstract]   [Full Text] [Related]  

  • 23. Artefactual atrial flutter.
    Kaltman JR; Shah MJ
    Cardiol Young; 2006 Apr; 16(2):195-6. PubMed ID: 16553987
    [No Abstract]   [Full Text] [Related]  

  • 24. Ultrafiltration controller failing: a case report.
    Stragier A; Maes T
    EDTNA ERCA J; 1997; 23(3):51-3. PubMed ID: 9664011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemofiltration circuit use beyond 72 hours in pediatric continuous renal replacement therapy.
    Ali FN; Lane JC
    Int J Artif Organs; 2012 Feb; 35(2):139-43. PubMed ID: 22388940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The technique of slow continuous ultrafiltration. Steps to maintain fluid balance without hemodynamic instability.
    Merrill RH
    J Crit Illn; 1991 Mar; 6(3):289-94. PubMed ID: 10147915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CAVH. Principles and practical applications.
    McAlpine L
    Crit Care Nurs Clin North Am; 1998 Jun; 10(2):179-89. PubMed ID: 9764011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Beta 2 microglobulin amyloidosis and biocompatibility of the membranes used for extrarenal blood purification].
    Fardellone P; Delacroix C; Renaud H; Brasseur J; Marie A; Sebert JL; Fournier A
    Rev Rhum Mal Osteoartic; 1989 Feb; 56(2):127-8. PubMed ID: 2657997
    [No Abstract]   [Full Text] [Related]  

  • 29. Validity of low-efficacy continuous renal replacement therapy in critically ill patients.
    Kawarazaki H; Uchino S
    Anaesthesiol Intensive Ther; 2016; 48(3):191-6. PubMed ID: 27240969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous renal replacement therapies in the treatment of acute renal failure in intensive care patients. Part 1. Theoretical aspects and techniques.
    Ronco C
    Nephrol Dial Transplant; 1994; 9 Suppl 4():191-200. PubMed ID: 7800257
    [No Abstract]   [Full Text] [Related]  

  • 31. Acid-base balance and replacement solutions in continuous renal replacement therapies.
    Feriani M; Dell'Aquila R
    Kidney Int Suppl; 1998 May; 66():S156-9. PubMed ID: 9573594
    [No Abstract]   [Full Text] [Related]  

  • 32. [Nursing in renal replacement therapy exemplified by continuous venovenous hemofiltration (CVVHF)].
    Lehmann C
    Kinderkrankenschwester; 2013 Apr; 32(4):148-51. PubMed ID: 23659143
    [No Abstract]   [Full Text] [Related]  

  • 33. Atrial flutter? An electrocardiographic artifact caused by the COBE PRISMA system.
    Biswas A; Thompson M
    Pediatr Nephrol; 1998 Aug; 12(6):524. PubMed ID: 9745881
    [No Abstract]   [Full Text] [Related]  

  • 34. Anaphylactoid reaction during first hemofiltration
with a PUREMA polysulfone membrane.
    Heegard KD; Tilley MA; Stewart IJ; Edgecombe HP; Lundy JB; Renz EM; Chung KK
    Int J Artif Organs; 2013 May; 36(5):363-6. PubMed ID: 23420464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microcirculatory perfusion derangements during continuous hemofiltration with fixed dose of ultrafiltration in stabilized intensive care unit patients.
    Veenstra G; Scheenstra B; Koopmans M; Kingma WP; Buter H; Boerma EC
    J Crit Care; 2014 Aug; 29(4):478-81. PubMed ID: 24642165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erosive osteoarthropathy associated with beta 2-microglobulin amyloidosis in a uraemic patient treated exclusively by long-term haemofiltration with biocompatible membranes.
    Renaud H; Fournier A; Moriniere P; Westeel PF; el Esper N; Belbrik S; Marie A; Cohen-Solal HE; Sebert JL
    Nephrol Dial Transplant; 1988; 3(6):820-2. PubMed ID: 3147427
    [No Abstract]   [Full Text] [Related]  

  • 37. Cellulose triacetate dialyzer reduces platelet loss during continuous veno-venous hemofiltration.
    Liu S; Shi W; Liang X; Su Y; Liang Y; Zhang B; Ye Z; Xu L; Xia Y; He C; Ma J; Tao Y; Ye H; Li H
    Blood Purif; 2010; 29(4):375-82. PubMed ID: 20484898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bench-to-bedside review: treating acid-base abnormalities in the intensive care unit--the role of renal replacement therapy.
    Naka T; Bellomo R
    Crit Care; 2004 Apr; 8(2):108-14. PubMed ID: 15025771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous arteriovenous hemodialysis in the ICU.
    Lawyer LA; Velasco A
    Crit Care Nurse; 1989 Jan; 9(1):29-41. PubMed ID: 2582788
    [No Abstract]   [Full Text] [Related]  

  • 40. [Dialysis and related procedures in the treatment of acute renal failure].
    Heinze V; Benzing F; Jäger H; Lüttgen F; Mielke G; Sümmerer H
    Verh Dtsch Ges Inn Med; 1989; 95():82-9. PubMed ID: 2603510
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.